BIOMAT Database Logo BIOMAT Database Logo

Drug-induced pseudolymphoma secondary to lamotrigine. 1998

P Pathak, and R S McLachlan
London Health Sciences Centre, Ontario, Canada.

UI MeSH Term Description Entries
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077213 Lamotrigine A phenyltriazine compound, sodium and calcium channel blocker that is used for the treatment of SEIZURES and BIPOLAR DISORDER. 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine,3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine,BW-430C,Crisomet,Labileno,Lamictal,Lamiktal,BW 430C,BW430C
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D014227 Triazines Heterocyclic rings containing three nitrogen atoms, commonly in 1,2,4 or 1,3,5 or 2,4,6 formats. Some are used as HERBICIDES. Triazine,Benzotriazines
D019310 Pseudolymphoma A group of disorders having a benign course but exhibiting clinical and histological features suggestive of malignant lymphoma. Pseudolymphoma is characterized by a benign infiltration of lymphoid cells or histiocytes which microscopically resembles a malignant lymphoma. (From Dorland, 28th ed & Stedman, 26th ed) Hyperplasia, Reactive Lymphoid,Lymphocytoma,Lymphoid Hyperplasia, Reactive,Hyperplasias, Reactive Lymphoid,Lymphocytomas,Lymphoid Hyperplasias, Reactive,Pseudolymphomas,Reactive Lymphoid Hyperplasia,Reactive Lymphoid Hyperplasias

Related Publications

P Pathak, and R S McLachlan
Drug induced pseudolymphoma secondary to ethosuximide.
November 2005, Journal of neurology, neurosurgery, and psychiatry,
P Pathak, and R S McLachlan
Lamotrigine-induced cutaneous pseudolymphoma.
August 2019, Cutis,
P Pathak, and R S McLachlan
[Drug-induced pseudolymphoma].
April 1980, Revista clinica espanola,
P Pathak, and R S McLachlan
[Drug induced pseudolymphoma].
May 1978, Zeitschrift fur Hautkrankheiten,
P Pathak, and R S McLachlan
Drug induced pseudolymphoma.
July 2018, Seminars in diagnostic pathology,
P Pathak, and R S McLachlan
Drug-induced pseudolymphoma syndrome.
January 1995, Indian journal of dermatology, venereology and leprology,
P Pathak, and R S McLachlan
Lamotrigine-related pseudolymphoma presenting as cervical lymphadenopathy.
January 2017, Epilepsy & behavior case reports,
P Pathak, and R S McLachlan
Cutaneous pseudolymphoma secondary to gabapentin.
October 2018, BMJ case reports,
P Pathak, and R S McLachlan
Drug-induced CD30+ T cell pseudolymphoma.
January 2009, European journal of dermatology : EJD,
P Pathak, and R S McLachlan
[Drug-induced pseudolymphoma with predominantly cutaneous manifestation].
January 1993, Annales de dermatologie et de venereologie,
Copied contents to your clipboard!